JeenJoo Kang - 03 Aug 2021 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role: Director
Signature: /s/ Leone Patterson Attorney-in-Fact for JeenJoo Kang
Issuer symbol: TNYA
Transactions as of: 03 Aug 2021
Net transactions value: $0
Form type: 4
Filing time: 04 Aug 2021, 18:30:46 UTC
Previous filing: 29 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNYA	Common Stock	Conversion of derivative security	$0	+12,500	+100%	$0.000000	25,000	03 Aug 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNYA	Series A Preferred Stock	Conversion of derivative security		-12,500	-100%		0	03 Aug 2021	Common Stock	12,500	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date.